Simmons D L, Wagner D, Westover K
Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Clin Infect Dis. 2000 Oct;31 Suppl 5:S211-8. doi: 10.1086/317517.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used antipyretic agents that most probably exert their antifever effect by inhibiting cyclooxygenase (COX)-2. Thus, COX-2-selective drugs or null mutation of the COX-2 gene reduce or prevent fever. Acetaminophen is antipyretic and analgesic, as are NSAIDs, but it lacks the anti-inflammatory and anticoagulatory properties of these drugs. This has led to the speculation that a COX variant exists that is inhibitable by acetaminophen. An acetaminophen-inhibitable enzyme is inducible in the mouse J774.2 monocyte cell line. Induction of acetaminophen-inhibitable prostaglandin E(2) synthesis parallels induction of COX-2. Thus, inhibition of pharmacologically distinct COX-2 enzyme activity by acetaminophen may be the mechanism of action of this important antipyretic drug.
非甾体抗炎药(NSAIDs)是常用的解热剂,很可能通过抑制环氧化酶(COX)-2发挥其退热作用。因此,COX-2选择性药物或COX-2基因无效突变可减轻或预防发热。对乙酰氨基酚具有解热和镇痛作用,NSAIDs也如此,但它缺乏这些药物的抗炎和抗凝特性。这引发了一种推测,即存在一种可被对乙酰氨基酚抑制的COX变体。在小鼠J774.2单核细胞系中可诱导出一种可被对乙酰氨基酚抑制的酶。对乙酰氨基酚抑制的前列腺素E2合成的诱导与COX-2的诱导平行。因此,可以认为对乙酰氨基酚对药理学上不同的COX-2酶活性的抑制作用可能是这种重要解热药物的作用机制。